We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Dionex to Purchase ESA Biosciences' HPLC Assets

By LabMedica International staff writers
Posted on 18 Sep 2009
Dionex Corporation (Sunnyvale, CA, USA), a provider of liquid chromatography analysis systems, has entered into an asset purchase agreement with ESA Biosciences (Chelmsford, MA, USA), a wholly owned subsidiary of Magellan Biosciences, Inc. More...
Dionex will purchase ESA Biosciences high performance liquid chromatography (HPLC) products, HPLC clinical assays, and laboratory services.

The agreement will give Dionex three lines of HPLC detectors. These products include the Corona universal charged aerosol detectors, which Dionex will sell with its own HPLC equipment or directly on third party systems. The other two product lines, the CoulArray and Coulocheme electrochemical detectors are targeted at clinical, metabolomics, and neuroscience applications.

Combined with Dionex expertise in electrochemistry detection for carbohydrates and glycobiology, this acquisition will position it as a leading provider of comprehensive electrochemistry solutions for liquid chromatography.

The terms of the transaction were not disclosed. Dionex anticipates that the transaction will generate additional revenue of US$12-$15 million and excluding one time charges will be slightly accretive in fiscal 2010. The transaction is expected to close by the end of September 2009.

Dionex is a manufacturer and marketer of ion chromatography, HPLC and sample preparation systems, accessories and consumables, and software products for chemical and life sciences applications. Dionex provides application solutions ranging from the identification and measurement of inorganic and organic ions, small organic molecules, as well as large biomolecules.

ESA Biosciences designs and manufactures a full range of specialty detectors, reagents, and total solutions. The products are used in neuroscience, clinical diagnostic, biomedical research, and industrial laboratories worldwide. Through its subsidiary, ESA Laboratories, Inc., the company also provides a range of analytical services ranging from industrial hygiene and clinical diagnostic analysis, to metabolomics profiling.

Related Links:

Dionex Corporation
ESA Biosciences



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.